Financial Results : Nahdi net profit up 3% to SAR 244.3 mln in Q1

Nahdi net profit up 3% to SAR 244.3 mln in Q1

10/05/2023 Argaam Exclusive

View other reports

Nahdi Medical Co. posted a net profit of SAR 244.3 million in Q1 2023, a 3% increase from SAR 237.5 million a year earlier.



Current Quarter Comparison (M)

Compared With The
Item Q1 2022 Q1 2023 Change‬
Revenues 2,079.49 2,105.04 1.2 %
Gross Income 851.73 889.20 4.4 %
Operating Income 255.15 260.20 2.0 %
Net Income 237.51 244.34 2.9 %
Average Shares 130.00 130.00 -
EPS (Riyals) 1.83 1.88 2.9 %

The positive performance was attributed to an increase of 1.2% year-on-year (YoY) in revenue to SAR 2.1 billion on growth in retail and healthcare business segments.

 

Gross profit increased by 4.1% YoY in Q1 2023 to SAR 886.9 million, driven by sales growth, private label growth, and positive product mix. As a result, the gross margin improved by 1.2% to 42.1% of revenue in Q1 from 41.0% in Q1 2022.

 

On the other hand, OpEx rose by 5.4% in Q1 2023 to SAR 629 million, mainly to support the business growth in line with the company's business plan.

 

Sequentially, net profit rose 90.9% from SAR 127.99 million in Q4 2022.

 

Shareholders’ equity, excluding minority interest, stood at SAR 2.08 billion as of March 31, 2023, compared to SAR 1.84 billion a year earlier.

Kindly, you can view the full report by subscribing to the

The report contains the details of the financial statements, The most important financial indicators, Historical information, Charts, and Forecasts of experts.


Comments {{getCommentCount()}}

Be the first to comment

{{Comments.indexOf(comment)+1}}
{{comment.FollowersCount}}
{{comment.CommenterComments}}
loader Train
Sorry: the validity period has ended to comment on this news
Opinions expressed in the comments section do not reflect the views of Argaam. Abusive comments of any kind will be removed. Political or religious commentary will not be tolerated.